Health · 4 views
FDA clears blood test to aid evaluation for Alzheimer's disease
The U.S. Food and Drug Administration cleared a new blood test for marketing.
Source Medical Xpress AI Summary Updated 39m ago
Health 
Story intelligence Beta
Confidence Limited Single-outlet story
Views 4 Community interest
Brief read 1 min ~48 words
AI Summary
The U.S. Food and Drug Administration cleared a new blood test for marketing. The test, called PrecivityAD2, uses technology invented at Washington University School of Medicine in St. Louis to help diagnose Alzheimer’s disease early. C2N Diagnostics, a WashU‑based startup, developed and validated the test before FDA approval.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Language skills stay strong in older adults, even while other cognitive abilities declineContinue reading
- Ebola Is Still Killing in Central Africa. These Groups Are Working To Save Lives.Continue reading
- High-intensity sprints can trigger molecular changes in the bloodstreamContinue reading
- Nurse practitioner trainees find themselves stymied by shortage of clinical mentorsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow